Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1 IPO registration
- 3.1 Amended and Restated Certificate of Incorporation of Norwell, Inc
- 3.2 Certificate of Amendment of Certificate of Incorporation
- 3.3 Certificate of Amendment of Certificate of Incorporation of Greenwich Lifesciences, Inc
- 3.5 Amended and Restated Bylaws
- 10.1 2019 Equity Incentive Plan
- 10.2 Indemnification Agreement
- 23.1 Consent of Malonebailey, LLP , Independent Registered Public Accounting Firm
Associated filings
- 8 Mar 21 424B3 Prospectus supplement
- 10 Nov 20 424B3 Prospectus supplement
- 28 Sep 20 424B4 Prospectus supplement with pricing info
- 28 Sep 20 424B4 Prospectus supplement with pricing info
- 25 Sep 20 EFFECT Notice of effectiveness
- 22 Sep 20 FWP Free writing prospectus
- 10 Sep 20 S-1/A IPO registration (amended)
- 9 Sep 20 S-1/A IPO registration (amended)
- 26 Jun 20 S-1/A IPO registration (amended)
- 23 Jun 20 FWP Free writing prospectus
- 23 Jun 20 S-1/A IPO registration (amended)
-
1 Jun 20 S-1 IPO registration
GLSI similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the inclusion in this Registration Statement on Form S-1 of our report dated April 2, 2020 with respect to the audited financial statements of Greenwich LifeSciences, Inc. for the years ended December 31, 2019 and 2018. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.
We also consent to the references to us under the heading “Experts” in such Registration Statement.
/s/ MaloneBailey, LLP
www.malonebailey.com
Houston, Texas
May 29, 2020